Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives $6,032.50 Average PT from Brokerages

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) have been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $6,032.50.

A number of brokerages recently commented on RBGLY. Sanford C. Bernstein raised Reckitt Benckiser Group from a “market perform” rating to an “outperform” rating in a research note on Monday, December 11th. Jefferies Financial Group cut Reckitt Benckiser Group from a “hold” rating to an “underperform” rating in a research note on Monday, December 11th. Finally, BNP Paribas raised Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research note on Tuesday, January 9th.

Check Out Our Latest Analysis on RBGLY

Reckitt Benckiser Group Price Performance

RBGLY stock opened at $10.89 on Friday. The business has a fifty day moving average price of $13.69 and a 200 day moving average price of $13.80. Reckitt Benckiser Group has a fifty-two week low of $10.66 and a fifty-two week high of $16.60. The company has a quick ratio of 0.36, a current ratio of 0.54 and a debt-to-equity ratio of 0.57.

Reckitt Benckiser Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Monday, June 3rd. Shareholders of record on Friday, April 12th will be paid a dividend of $0.2701 per share. The ex-dividend date is Thursday, April 11th. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.18.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.

Recommended Stories

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.